AG99 Glaxosmsc 5.25%

RNS Number:5156U
GlaxoSmithKline Capital PLC
05 April 2007

Publication of Final Terms

The following Final Terms is available for viewing:

Final Terms dated 4 April, 2007 in relation to the issue by GlaxoSmithKline
Capital plc, and guanateed by GlaxoSmithKline plc, of #1 billion 5.35% Fixed
Rate Notes due 10 April 2042

To view the full document, please paste the following URL into the address bar 
of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/5156u_-2007-4-5.pdf

For further information, please contact:

GlaxoSmithKline
980 Great West Road
Brentford
Middlesex
TW8 9GS

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Final Terms may be addressed
to and/or targeted at persons who are residents of particular countries
(specified in the Offering Circular to the EMTN programme and/or the Final
Terms) only and is not intended for use and should not be relied upon by any
person outside these countries and/or to whom the offer contained in the Final
Terms is not addressed. Prior to relying on the information contained in the
Final Terms you must ascertain from the Final Terms whether or not you are part
of the intended addressees of the information contained therein. 

Your right to access this service is conditional upon complying with the above 
requirement.  



                      This information is provided by RNS
            The company news service from the London Stock Exchange

END

PDIXELFBDZBFBBL

Glaxosmsc 5.25% (LSE:AG99)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024

Glaxosmsc 5.25% (LSE:AG99)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024